CATALOGO DEI PRODOTTI DELLA RICERCA

CORBO, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.271
NA - Nord America 6.711
AS - Asia 5.256
SA - Sud America 761
AF - Africa 172
OC - Oceania 45
Continente sconosciuto - Info sul continente non disponibili 2
Totale 20.218
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.534
RU - Federazione Russa 2.826
SG - Singapore 2.045
CN - Cina 1.492
GB - Regno Unito 1.307
IT - Italia 1.103
BR - Brasile 595
HK - Hong Kong 557
VN - Vietnam 480
DE - Germania 407
IE - Irlanda 305
SE - Svezia 298
FR - Francia 290
FI - Finlandia 208
KR - Corea 154
NL - Olanda 144
IN - India 102
CA - Canada 90
JP - Giappone 68
UA - Ucraina 68
AT - Austria 67
ES - Italia 59
AR - Argentina 56
TR - Turchia 47
BD - Bangladesh 46
MX - Messico 45
ID - Indonesia 44
AU - Australia 40
PL - Polonia 38
NG - Nigeria 36
IQ - Iraq 35
ZA - Sudafrica 31
BE - Belgio 30
EC - Ecuador 29
CO - Colombia 26
TG - Togo 24
UZ - Uzbekistan 22
BJ - Benin 18
JO - Giordania 18
PK - Pakistan 18
MA - Marocco 17
CZ - Repubblica Ceca 16
LT - Lituania 16
VE - Venezuela 16
CH - Svizzera 15
IR - Iran 15
SA - Arabia Saudita 15
PH - Filippine 13
PY - Paraguay 13
MY - Malesia 11
CL - Cile 10
KE - Kenya 10
TN - Tunisia 10
AZ - Azerbaigian 9
PT - Portogallo 9
AL - Albania 8
CR - Costa Rica 8
JM - Giamaica 8
BG - Bulgaria 7
EG - Egitto 7
IL - Israele 7
NP - Nepal 7
GR - Grecia 6
NI - Nicaragua 6
PE - Perù 6
RS - Serbia 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
HN - Honduras 5
KG - Kirghizistan 5
NZ - Nuova Zelanda 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
TW - Taiwan 5
ET - Etiopia 4
HR - Croazia 4
HU - Ungheria 4
KZ - Kazakistan 4
LB - Libano 4
LV - Lettonia 4
PA - Panama 4
RO - Romania 4
BN - Brunei Darussalam 3
DK - Danimarca 3
DZ - Algeria 3
EE - Estonia 3
GT - Guatemala 3
MD - Moldavia 3
OM - Oman 3
SN - Senegal 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
CI - Costa d'Avorio 2
CY - Cipro 2
GE - Georgia 2
LK - Sri Lanka 2
NO - Norvegia 2
TT - Trinidad e Tobago 2
Totale 20.191
Salva come PNG Salva come JPEG
Città #
Southend 1.100
Singapore 1.050
Moscow 959
Ashburn 883
Chandler 706
San Jose 660
Dallas 608
Hong Kong 536
Verona 522
Beijing 322
Dublin 289
Jacksonville 237
The Dalles 224
Ann Arbor 220
Woodbridge 206
New York 198
Los Angeles 148
Ho Chi Minh City 134
Munich 130
Hanoi 118
Council Bluffs 110
Jinan 107
Lawrence 97
Princeton 97
Houston 92
Wilmington 91
Redmond 83
Shenyang 69
Nanjing 67
São Paulo 67
Helsinki 65
Orem 59
Redondo Beach 59
Tokyo 57
Santa Clara 56
Buffalo 50
London 50
Turku 50
Hebei 49
Milan 49
Tianjin 47
Columbus 43
Amsterdam 42
Sindelfingen 41
Vienna 40
Zhengzhou 40
Haikou 38
Warsaw 36
Abuja 35
Changsha 35
Chennai 34
Denver 34
Frankfurt am Main 34
Ningbo 34
Dearborn 33
Seattle 33
Brooklyn 32
Hangzhou 31
Nuremberg 31
Brussels 30
Dong Ket 28
Montreal 28
Lappeenranta 27
Madrid 27
Stockholm 27
Guangzhou 25
Toronto 25
Bologna 24
Jakarta 24
Lomé 24
San Francisco 24
Taiyuan 24
Chicago 22
Poplar 22
Redwood City 22
Boardman 21
Haiphong 21
Manchester 21
Rome 21
Johannesburg 20
Taizhou 20
Ankara 19
Barnet 19
Nanchang 19
Boston 18
Cotonou 18
Falkenstein 18
Sydney 18
Tashkent 18
Jiaxing 17
Phoenix 17
Atlanta 16
Mexico City 16
Norwalk 16
Paris 16
Amman 15
Brescia 15
Da Nang 15
Rio de Janeiro 15
Seoul 15
Totale 12.214
Salva come PNG Salva come JPEG
Nome #
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 291
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 285
Whole-genome landscape of pancreatic neuroendocrine tumours 280
DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples 275
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 251
Genomic analyses identify molecular subtypes of pancreatic cancer 251
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 244
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 237
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. 229
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 214
RON is not a prognostic marker for resectable pancreatic cancer 209
MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases 207
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 204
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 203
Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer 200
Complete neural stem cell (nsc) neuronal differentiation requires a branched chain amino acids-induced persistent metabolic shift towards energy metabolism 196
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 196
Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation 193
Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data 192
Reporting tumor molecular heterogeneity in histopathological diagnosis 190
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 188
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer 188
Lost in translation: returning germline genetic results in genome-scale cancer research 186
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation 186
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 184
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 183
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer 183
Comparative Lesions Analysis Through a Targeted Sequencing Approach 182
Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice 180
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma 179
Molecular biology of neuroendocrine tumors 179
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 179
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo 179
Clinical Application of MicroRNA Testing in Neuroendocrine Tumors of the Gastrointestinal Tract. 178
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 177
Hypermutation In Pancreatic Cancer 174
Fhit down-regulation is an early event in pancreatic carcinogenesis 174
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 172
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 171
Pancreatic cancer genomics 171
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 171
Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study 170
Divergent mutational processes distinguish hypoxic and normoxic tumours 169
Cell Lineage Infidelity in PDAC Progression and Therapy Resistance 169
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing 168
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan 168
Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries 167
Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models 167
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 167
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 166
Sex differences in oncogenic mutational processes 166
Loss of FGFR4 promotes the malignant phenotype of PDAC 164
Molecular Pathology of Pancreatic Cancer: from bench-to-bedside translation. 164
Mutational analysis of cancer candidate genes in different pancreatic cancer types 163
Combinatorial Effect of Magnetic Field and Radiotherapy in Pancreatic Ductal Adenocarcinoma Organoids 163
Exosomal miRNA signatures of pancreatic lesions 160
Author Correction: The landscape of viral associations in human cancers 159
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis 158
Next-Generation Histopathologic Diagnosis: A Lesson From a Hepatic Carcinosarcoma 157
Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients 156
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 155
Local ablation disrupts immune evasion in pancreatic cancer 154
Molecular alterations in basal cell carcinoma subtypes 154
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer 153
From Genetic Alterations to Tumor Microenvironment: The Ariadne's String in Pancreatic Cancer 153
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 153
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. 150
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 149
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer 148
Potential role of RICTOR copy number gain (CNG) as a key biomarker of mTOR activity: A comprehensive preclinical analysis in squamous cell lung cancer (SQLC) models 148
Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium 147
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 147
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 147
Generation of Pancreatic Organoid-Derived Isografts 146
Long-term organoid culture of a small intestinal neuroendocrine tumor 145
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes 144
Muscle derangement and alteration of the nutritional machinery in NSCLC 144
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC 142
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer 141
Whole genomes redefine the mutational landscape of pancreatic cancer 141
Profiling mTOR pathway in neuroendocrine tumors. 141
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association 141
Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling 138
Profiling mTOR pathway in neuroendocrine tumors 135
Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care 134
Combined burden and functional impact tests for cancer driver discovery using DriverPower 134
Update on the molecular pathogenesis of pancreatic tumors other than common ductal adenocarcinoma 133
Mutational profile of GNAQQ209 in human tumors 131
MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC 130
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer 130
Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterization 129
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 129
Current role of non-coding RNAs in the clinical setting 129
Author Correction: Pan-cancer analysis of whole genomes 129
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer 128
Preclinical Modelling of PDA: Is Organoid the New Black? 128
Mutational profiling of kinases in human tumours of pancreatic origin identifies candidate cancer genes in ductal and ampulla of vater carcinomas 125
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer 124
Comprehensive molecular characterization of mitochondrial genomes in human cancers 124
Impact of COVID-19 on Pancreatic Cancer Research and the Path Forward 124
Totale 17.009
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.028
article - articoli 60.296
book - libri 0
conference - conferenze 2.318
curatela - curatele 0
other - altro 2.047
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.367
Totale 132.056
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021187 0 0 0 0 0 0 0 0 0 25 79 83
2021/2022979 95 311 33 50 39 37 29 58 35 16 76 200
2022/20231.889 113 222 150 328 160 453 23 115 230 19 41 35
2023/20241.225 43 76 78 106 139 211 61 144 29 85 186 67
2024/20253.647 179 161 177 529 201 179 245 216 524 251 373 612
2025/20269.468 691 491 705 1.582 2.524 618 906 530 828 593 0 0
Totale 20.544